Kaye, Elena A.
Cornelis, Francois H.
Petre, Elena N.
Tyagi, Neelam
Shady, Waleed
Shi, Weiji
Zhang, Zhigang
Solomon, Stephen B.
Sofocleous, Constantinos T.
Durack, Jeremy C.
Funding for this research was provided by:
NIH (CA008748)
Article History
Received: 10 July 2018
Revised: 13 September 2018
Accepted: 27 September 2018
First Online: 6 November 2018
Compliance with ethical standards
:
: The scientific guarantor of this publication is Dr. Elena Kaye.
: The authors of this manuscript declare relationships with the following companies.C. T. Sofocleous has received research support from BTG, Ethicon (Neuwave); HS Medical, Angiodynamics; Sota Medical; and is a consultant for Ethicon and GE.S. B. Solomon is a shareholder of Johnson & Johnson, Adgero, Immunomedics, Aspire Bariatrics, and Progenics; has received personal fees from Medtronics, BTG, Astra Zeneca, and Johnson & Johnson; and has a research grant from GE Heathcare.J. Durack is an investor in and is on scientific advisory board of Adient Medical.E. Kaye received consulting fees from Galil Medical.The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: Weiji Shi, PhD and Zhigang Zhang, PhD kindly provided statistical advice for this manuscript.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in:1. Shady W, Petre EN, Gonen M, et al Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes—a 10-year experience at a single center. Radiology. 2015;278:601–11.2. Wang X, Sofocleous CT, Erinjeri JP, et al Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol 2013;36(1):166–175.3. Sofocleous CT, Garg S, Petrovic LM, et al Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol 2012;19(13):4262–4269.4. Sofocleous CT, Petre EN, Gonen M, et al CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol 2011;22(6):755–761.
: • Retrospective• Diagnostic or prognostic study• Performed at one institution